BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/4/2018 3:36:30 AM | Browse: 461 | Download: 822
Publication Name World Journal of Clinical Oncology
Manuscript ID 39548
Country/Territory Mexico
Received
2018-04-27 01:52
Peer-Review Started
2018-04-27 03:23
To Make the First Decision
2018-06-15 02:43
Return for Revision
2018-06-15 03:43
Revised
2018-06-22 05:16
Second Decision
2018-06-28 10:10
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-06-29 01:27
Articles in Press
2018-06-29 01:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-08-09 07:20
Publish the Manuscript Online
2018-08-13 07:12
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer
Manuscript Source Invited Manuscript
All Author List Angeles C Tecalco-Cruz and Josué O Ramírez-Jarquín
Funding Agency and Grant Number
Funding Agency Grant Number
DGAPA-UNAM-PAPIIT IA200916
DGAPA-UNAM-PAPIIT IA201618
Corresponding Author Angeles C Tecalco-Cruz, PhD, Full Professor, Programa de Investigación de Cáncer de Mama (PICM), Departamento de Biología Moleculary Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad Universitaria, México 04510, Mexico. 12anget@gmail.com
Key Words Estrogen receptor alpha polyubiquitination; Breast cancer; Estrogen receptor alpha
Core Tip The inhibition of the estrogen receptor alpha polyubiquitination and degradation by several molecular mechanisms is related to the progression of breast cancer and resistance to endocrine therapy.
Publish Date 2018-08-13 07:12
Citation Tecalco-Cruz AC, Ramírez-Jarquín JO. Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer. World J Clin Oncol 2018; 9(4): 60-70
URL http://www.wjgnet.com/2218-4333/full/v9/i4/60.htm
DOI http://dx.doi.org/10.5306/wjco.v9.i4.60
Full Article (PDF) WJCO-9-60.pdf
Full Article (Word) WJCO-9-60.doc
Manuscript File 39548-Review.docx
Answering Reviewers 39548-Answering reviewers.pdf
Audio Core Tip 39548-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 39548-Conflict-of-interest statement.pdf
Copyright License Agreement 39548-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 39548-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 39548-Language certificate.pdf
Peer-review Report 39548-Peer-review(s).pdf
Scientific Misconduct Check 39548-Scientific misconduct check.pdf
Scientific Editor Work List 39548-Scientific editor work list.pdf